Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
18,810,702
-
Total 13F shares
-
18,555,217
-
Share change
-
-41,513
-
Total reported value
-
$955,048,309
-
Put/Call ratio
-
1600%
-
Price per share
-
$51.47
-
Number of holders
-
180
-
Value change
-
-$1,816,172
-
Number of buys
-
84
-
Number of sells
-
72
Institutional Holders of LEMAITRE VASCULAR INC - Common Stock (LMAT) as of Q1 2023
As of 31 Mar 2023,
LEMAITRE VASCULAR INC - Common Stock (LMAT) was held by
180 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,555,217 shares.
The largest 10 holders included
BlackRock Inc., Conestoga Capital Advisors, LLC, VANGUARD GROUP INC, Copeland Capital Management, LLC, Ranger Investment Management, L.P., GENEVA CAPITAL MANAGEMENT LLC, STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, GEODE CAPITAL MANAGEMENT, LLC, and CRAMER ROSENTHAL MCGLYNN LLC.
This page lists
180
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.